Enanta Pharmaceuticals(DE:9EP)
€10.40+0.50 (+5.05%)
DE:9EP
Enanta Pharmaceuticals earnings date
€10.40
At close:+0.50 (+5.05%)
Enanta Pharmaceuticals (9EP) Q2 2023 Earnings Report
0 Followers
DE:9EP Q2 2023 EPS Results
- Actual EPS
- -EUR 1.62
- Consensus EPS
- -EUR 1.77
- Beat/Miss
- Beat by +EUR 0.16
- One Year Ago EPS
- -EUR 1.47
DE:9EP Q2 2023 Revenue Results
- Actual Revenue
- EUR 16.09M
- Expected Revenue
- EUR 17.21M
- Beat/Miss
- Missed by -EUR 1.13M
- YoY Revenue Growth
- -4.92%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 05/08/2023
- Time
- After Close
- Conference Call
- Monday, May 8, 2023
DE:9EP Upcoming Earnings
Enanta Pharmaceuticals's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2023 Earnings Call Audio
DE:9EP Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:9EP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q4) | -0.65- | -0.79 | ― | ― |
| Aug 10, 2026 | 2026 (Q3) | -0.46-0.61 | -0.77 | 21.18% (+0.16) | |
| May 11, 2026 | 2026 (Q2) | -0.44-0.41 | -0.96 | 57.55% (+0.55) | |
| Feb 09, 2026 | 2026 (Q1) | -0.69-0.38 | -0.95 | 60.00% (+0.57) | |
| Nov 17, 2025 | 2025 (Q4) | -0.92-0.79 | -1.23 | 36.03% (+0.44) | |
| Aug 11, 2025 | 2025 (Q3) | -0.81-0.77 | -0.97 | 20.56% (+0.20) | |
| May 12, 2025 | 2025 (Q2) | -1.04-0.96 | -1.33 | 27.89% (+0.37) | |
| Feb 10, 2025 | 2025 (Q1) | -1.22-0.95 | -1.43 | 33.54% (+0.48) | |
| Nov 25, 2024 | 2024 (Q4) | -1.05-1.23 | -1.2 | -2.26% (-0.03) | |
| Aug 05, 2024 | 2024 (Q3) | -1.29-0.97 | -1.68 | 42.47% (+0.71) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
